ENHERTU® Significantly Improved Both Progression-Free and Overall Survival in DESTINY-Breast04 Trial in Patients with HER2 Low Metastatic Breast Cancer
Daiichi Sankyo
2022-02-21 12:51:35
ENHERTU® Significantly Improved Both Progression-Free and Overall Survival in DESTINY-Breast04 Trial in
Trastuzumab Deruxtecan Type II Variation Application Validated by EMA for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen
Daiichi Sankyo
2021-12-28 09:57:56
Trastuzumab Deruxtecan Type II Variation Application Validated by EMA for Patients with HER2 Positive
Enter your username and password here in order to log in on the website
Dear User,
This website provides you with information only for healthcare professionals. According to the drug
promotion code, we are only able to allow healthcare professionals like physicians and pharmacists to have
full access to our website. To visit our page please login.
Dear User,
This website provides you with information only for healthcare professionals. According to the drug
promotion code, we are only able to allow healthcare professionals like physicians and pharmacists to have
full access to our website. To visit our page please login.
This Website uses cookies which are essential for providing
our services and core website functionality. In addition, if you
click on "I AGREE", we will further use analytical and
advertising cookies to analyse your use of our Website so that
we can improve its functionality and display content tailored
according to your interests and preferences, including on third
party websites. We use Google Analytics and its tracking and
remarketing features connected with Google Ads. This means that
cookies on your device will be placed and accessed by Google LLC
in the USA enabling us and third parties participating in the
Google advertising network to conduct conversion tracking and
remarketing activities across different websites and devices. By
accepting analytical and advertising cookies you consent to the
respective processing and sharing of your personal data with
Google LLC. You can withdraw your consent and change your cookie
preferences at any time by using our
Cookie preferences tool
. To refuse consent and
continue without analytical and advertising cookies, please
click on "I DO NOT AGREE". For more information see our
Privacy policy
.
You are now leaving our website. Please note that our terms of use (especially those mentioned under "Disclaimer" and "Imprint") are no longer valid as soon as you click on the "Continue" button. As we do not have any influence on linked websites, we assume no liability for their content. If you would like to return to our website, please click the "Return" button.